ADC Therapeutics's total assets for Q3 2025 were $289.76M, a decrease of -9.89% from the previous quarter. ADCT total liabilities were $527.94M for the fiscal quarter, a 1.38% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.